Literature DB >> 24803511

Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.

Ryan E Wiegand1, Charles E Rose2, John M Karon3.   

Abstract

A potential difficulty in the analysis of biomarker data occurs when data are subject to a detection limit. This detection limit is often defined as the point at which the true values cannot be measured reliably. Multiple, regression-type models designed to analyze such data exist. Studies have compared the bias among such models, but few have compared their statistical power. This simulation study provides a comparison of approaches for analyzing two-group, cross-sectional data with a Gaussian-distributed outcome by exploring statistical power and effect size confidence interval coverage of four models able to be implemented in standard software. We found using a Tobit model fit by maximum likelihood provides the best power and coverage. An example using human immunodeficiency virus type 1 ribonucleic acid data is used to illustrate the inferential differences in these models.
© The Author(s) 2014.

Entities:  

Keywords:  limit of detection; regression; statistical power

Mesh:

Substances:

Year:  2014        PMID: 24803511      PMCID: PMC6880228          DOI: 10.1177/0962280214531684

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  53 in total

1.  A simple method for converting an odds ratio to effect size for use in meta-analysis.

Authors:  S Chinn
Journal:  Stat Med       Date:  2000-11-30       Impact factor: 2.373

2.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

3.  Ordinal regression model and the linear regression model were superior to the logistic regression models.

Authors:  Colleen M Norris; William A Ghali; L Duncan Saunders; Rollin Brant; Diane Galbraith; Peter Faris; Merril L Knudtson
Journal:  J Clin Epidemiol       Date:  2006-03-14       Impact factor: 6.437

4.  Relaxing the rule of ten events per variable in logistic and Cox regression.

Authors:  Eric Vittinghoff; Charles E McCulloch
Journal:  Am J Epidemiol       Date:  2006-12-20       Impact factor: 4.897

5.  Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.

Authors:  Joseph J Eron; Benjamin Young; David A Cooper; Michael Youle; Edwin Dejesus; Jaime Andrade-Villanueva; Cassy Workman; Roberto Zajdenverg; Gerd Fätkenheuer; Daniel S Berger; Princy N Kumar; Anthony J Rodgers; Melissa A Shaughnessy; Monica L Walker; Richard J O Barnard; Michael D Miller; Mark J Dinubile; Bach-Yen Nguyen; Randi Leavitt; Xia Xu; Peter Sklar
Journal:  Lancet       Date:  2010-01-12       Impact factor: 79.321

Review 6.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

7.  Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.

Authors:  Christopher D Pilcher; George Joaki; Irving F Hoffman; Francis E A Martinson; Clement Mapanje; Paul W Stewart; Kimberly A Powers; Shannon Galvin; David Chilongozi; Syze Gama; Matthew A Price; Susan A Fiscus; Myron S Cohen
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

8.  Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

Authors:  David A Cooper; Roy T Steigbigel; Jose M Gatell; Jurgen K Rockstroh; Christine Katlama; Patrick Yeni; Adriano Lazzarin; Bonaventura Clotet; Princy N Kumar; Joseph E Eron; Mauro Schechter; Martin Markowitz; Mona R Loutfy; Jeffrey L Lennox; Jing Zhao; Joshua Chen; Desmond M Ryan; Rand R Rhodes; John A Killar; Lucinda R Gilde; Kim M Strohmaier; Anne R Meibohm; Michael D Miller; Daria J Hazuda; Michael L Nessly; Mark J DiNubile; Robin D Isaacs; Hedy Teppler; Bach-Yen Nguyen
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Authors:  Gerd Fätkenheuer; Mark Nelson; Adriano Lazzarin; Irina Konourina; Andy I M Hoepelman; Harry Lampiris; Bernard Hirschel; Pablo Tebas; François Raffi; Benoit Trottier; Nicholaos Bellos; Michael Saag; David A Cooper; Mike Westby; Margaret Tawadrous; John F Sullivan; Caroline Ridgway; Michael W Dunne; Steve Felstead; Howard Mayer; Elna van der Ryst
Journal:  N Engl J Med       Date:  2008-10-02       Impact factor: 176.079

10.  Epidemiologic evaluation of measurement data in the presence of detection limits.

Authors:  Jay H Lubin; Joanne S Colt; David Camann; Scott Davis; James R Cerhan; Richard K Severson; Leslie Bernstein; Patricia Hartge
Journal:  Environ Health Perspect       Date:  2004-12       Impact factor: 9.031

View more
  6 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Two-part test of vaccine effect.

Authors:  Zonghui Hu; Michael Proschan
Journal:  Stat Med       Date:  2015-01-29       Impact factor: 2.373

3.  An Evaluation of Statistical Methods for Analyzing Follow-Up Gaussian Laboratory Data with a Lower Quantification Limit.

Authors:  John M Karon; Ryan E Wiegand; Janneke H van de Wijgert; Peter H Kilmarx
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

4.  Analysis of False-Negative Human Immunodeficiency Virus Rapid Tests Performed on Oral Fluid in 3 International Clinical Research Studies.

Authors:  Marcel E Curlin; Roman Gvetadze; Wanna Leelawiwat; Michael Martin; Charles Rose; Richard W Niska; Tebogo M Segolodi; Kachit Choopanya; Jaray Tongtoyai; Timothy H Holtz; Taraz Samandari; Janet M McNicholl
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

5.  A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection.

Authors:  Sandipan Dutta; Susan Halabi
Journal:  Pharm Stat       Date:  2021-04-14       Impact factor: 1.894

6.  A Comparison of Methods for Analyzing Viral Load Data in Studies of HIV Patients.

Authors:  Charles E Rose; Lytt Gardner; Jason Craw; Sonali Girde; Andrew J Wawrzyniak; Mari-Lynn Drainoni; Jessica Davila; Jack DeHovitz; Jeanne C Keruly; Andrew O Westfall; Gary Marks
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.